What is Supernus Pharmaceuticals's net change in cash?

Supernus Pharmaceuticals (SUPN) reported net change in cash of $56.42M in Q1 2026.

How has Supernus Pharmaceuticals's net change in cash changed year-over-year?

Supernus Pharmaceuticals's net change in cash increased by 21.3% year-over-year, from $46.52M to $56.42M.

What does net change in cash mean?

Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.

Supernus Pharmaceuticals SUPN Net Change in Cash

Net Change in Cash at other companies

AbbVieABBV

$4.16B+1,293%

Rapport Therapeutics, Inc.RAPP

$25.41M+3,080%

Axsome TherapeuticsAXSM

-$17.83M-23.4%

Neurocrine BiosciencesNBIX

-$446.5M-1,048%

Jazz PharmaceuticalsJAZZ

$452.4M+182%

Acadia PharmaceuticalsACAD

$104.52M+203%

Other financials

Income statement

See full

Revenue$207.7M+38.6%

Gross profit$184.3M+37.5%

Operating income-$8.3M+18.8%

Net income-$2.3M+80.6%

EPS (diluted)-$0.04+81.0%

Balance sheet

See full

Cash & equivalents$186.3M+60.8%

Total debt$40.9M+26.6%

Total equity$1.1B+4.5%

Total assets$1.5B+11.4%

Cash flow

See full

Operating cash flow$66.5M+117%

CapEx--100%

Free cash flow$66.5M+120%

Valuation

See full

Market cap$2.58B+62.8%

Enterprise value$2.44B+62.3%

P/S3.3×+0.9×

Profitability

See full

Gross margin89.4%+1.0pp

Operating margin-7.8%-18.9pp

Net margin-3.7%-13.0pp

FCF margin27.9%+3.4pp

Returns & leverage

See full

Return on equity-2.8%-9.1pp

Debt / equity0×0.0×

Current ratio2×-0.5×

Where this comes from

Reported directly by Supernus Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect.

The official record: Supernus Pharmaceuticals’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Supernus Pharmaceuticals's net change in cash.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Supernus Pharmaceuticals's net change in cash?: Supernus Pharmaceuticals (SUPN) reported net change in cash of $56.42M in Q1 2026.
How has Supernus Pharmaceuticals's net change in cash changed year-over-year?: Supernus Pharmaceuticals's net change in cash increased by 21.3% year-over-year, from $46.52M to $56.42M.
What does net change in cash mean?: Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.